摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氨基-1-(3-溴苯基)乙酮盐酸盐 | 61858-39-7

中文名称
2-氨基-1-(3-溴苯基)乙酮盐酸盐
中文别名
2'-氨基-3-溴苯乙酮盐酸盐
英文名称
2-amino-1-(3-bromophenyl)ethanone hydrochloride
英文别名
2-amino-1-(3-bromo-phenyl)-ethanone; hydrochloride;2-Amino-1-(3-brom-phenyl)-aethanon; Hydrochlorid;2-m-bromophenyl-2-oxoethylamine hydrochloride;[2-(3-Bromophenyl)-2-oxoethyl]azanium;chloride
2-氨基-1-(3-溴苯基)乙酮盐酸盐化学式
CAS
61858-39-7
化学式
C8H8BrNO*ClH
mdl
——
分子量
250.523
InChiKey
UBJDGVBOZSLUCW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.01
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    43.1
  • 氢给体数:
    2
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2922399090

SDS

SDS:e46f8e07c8dc591660335e5cdd37089a
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-amino-1-(3-bromophenyl)ethanone, HCl
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-amino-1-(3-bromophenyl)ethanone, HCl
CAS number: 61858-39-7

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H9BrClNO
Molecular weight: 250.5

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    2-氨基-1-(3-溴苯基)乙酮盐酸盐N-甲基吗啉甲酸六氯乙烷 、 benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate 、 三乙胺N,N-二异丙基乙胺三苯基膦 作用下, 以 四氢呋喃二氯甲烷乙腈 为溶剂, 反应 55.5h, 生成 2-(2-(5-(3-bromophenyl)oxazol-2-yl)-2-oxoethyl) 1-(tert-butyl) (S)-pyrrolidine-1,2-dicarboxylate
    参考文献:
    名称:
    [EN] HEPATITIS C VIRUS INHIBITORS
    [FR] INHIBITEURS DU VIRUS DE L'HÉPATITE C
    摘要:
    这项披露涉及到公式(I)中定义的新化合物或规范中定义的化合物,以及包含这些新化合物的组合物。这些化合物是有用的抗病毒剂,特别是在抑制由丙型肝炎病毒(HCV)编码的NS5A蛋白的功能方面。因此,该披露还涉及通过使用这些新化合物或包含这些新化合物的组合物来治疗HCV相关疾病或症状的方法。
    公开号:
    WO2011060000A1
  • 作为产物:
    描述:
    2-叠氮基-1-(3-溴苯基)乙酮 在 tin(II) chloride dihdyrate 作用下, 以 乙酸乙酯 为溶剂, 反应 3.0h, 生成 2-氨基-1-(3-溴苯基)乙酮盐酸盐
    参考文献:
    名称:
    [EN] HEPATITIS C VIRUS INHIBITORS
    [FR] INHIBITEURS DU VIRUS DE L'HÉPATITE C
    摘要:
    这项披露涉及到公式(I)中定义的新化合物或规范中定义的化合物,以及包含这些新化合物的组合物。这些化合物是有用的抗病毒剂,特别是在抑制由丙型肝炎病毒(HCV)编码的NS5A蛋白的功能方面。因此,该披露还涉及通过使用这些新化合物或包含这些新化合物的组合物来治疗HCV相关疾病或症状的方法。
    公开号:
    WO2011060000A1
点击查看最新优质反应信息

文献信息

  • [EN] IMIDAZOPYRIMIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION<br/>[FR] MACROCYCLES D'IMIDAZOPYRIMIDINE UTILISÉS COMME INHIBITEURS DE LA RÉPLICATION DU VIRUS DE L'IMMUNODÉFICIENCE HUMAINE
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2015126758A1
    公开(公告)日:2015-08-27
    The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection. I
    该披露通常涉及到I式化合物,包括用于治疗人类免疫缺陷病毒(HIV)感染的组合物和方法。该披露提供了HIV的新型抑制剂,含有这些化合物的药物组合物,以及在治疗HIV感染中使用这些化合物的方法。
  • The reaction of prop-2-ynylsulfonium salts and sulfonyl-protected β-amino ketones to epoxide-fused 2-methylenepyrrolidines and S-containing pyrroles
    作者:Tingting Jia、Gongruixue Zeng、Chong Zhang、Linghui Zeng、Wenya Zheng、Siyao Li、Keyi Wu、Jiaan Shao、Jiankang Zhang、Huajian Zhu
    DOI:10.1039/d0cc07745c
    日期:——
    A novel divergent domino annulation reaction of prop-2-ynylsulfonium salts with sulfonyl-protected β-amino ketones has been developed, affording various epoxide-fused 2-methylenepyrrolidines and S-containing pyrroles in moderate to excellent yields. Prop-2-ynylsulfonium salts act as C2 synthons in the reactions providing a promising epoxide-fused skeleton in a single operation with readily accessible
    已经开发了丙-2-炔基salts盐与磺酰基保护的β-氨基酮的新型发散性多米诺环化反应,以中等到极好的收率提供了各种环氧化物稠合的2-亚甲基吡咯烷和含S的吡咯。丙-2-炔基salts盐在反应中充当C 2合成子,可通过易于操作的起始原料在单次操作中提供有希望的环氧融合骨架。
  • [EN] MACROCYCLIC INHIBITORS OF MYELOPEROXIDASE<br/>[FR] INHIBITEURS MACROCYCLIQUES DE MYELOPEROXIDASE
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2018005336A1
    公开(公告)日:2018-01-04
    The present invention provides compounds of Formula (I): wherein the substituents are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and/or eosinophil peroxidase (EPX) inhibitors, and may be useful for for the treatment and/or prophylaxis of atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD), and related diseases.
    本发明提供了式(I)的化合物:其中取代基如规范中所定义,并包括任何此类新化合物的组合物。这些化合物是髓过氧化物酶(MPO)抑制剂和/或嗜酸性粒细胞过氧化物酶(EPX)抑制剂,可能对动脉粥样硬化、心力衰竭、慢性阻塞性肺病(COPD)及相关疾病的治疗和/或预防有用。
  • An approach to the synthesis of 4-aryl and 5-aryl substituted thiazole-2(3H)-thiones employing flow processing
    作者:Monaem Balti、Shelli A. Miller、Mohamed Lotfi Efrit、Nicholas E. Leadbeater
    DOI:10.1039/c6ra15488c
    日期:——
    A method for the preparation of 4-aryl and 5-aryl substituted thiazole-2(3H)-thiones is described. Flow processing is employed as a tool, and supported acids and bases used to facilitate both the synthetic strategy and product isolation. The methodology is applicable to a range of substrates.
    描述了一种制备4-芳基和5-芳基取代的噻唑-2(3H)-硫酮的方法。流动加工被用作工具,并且负载的酸和碱用于促进合成策略和产物分离。该方法适用于多种基材。
  • Novel substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them
    申请人:——
    公开号:US20030171364A1
    公开(公告)日:2003-09-11
    The invention relates to novel substituted pyrazolo[4,3-e]-diazepines of general formula (I), to pharmaceutical compositions containing them, to their use as medicinal products and to processes for preparing them.
    这项发明涉及一种新型的取代吡唑并[4,3-e]-二氮杂环庚烷的一般式(I),以及含有它们的药物组合物,它们作为药物的用途以及制备它们的方法。
查看更多